Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes One Patent, One Patent Application Related to RNAi

Premium
Title: Transport of Nucleotides, Oligonucleotides, and Polynucleotides into the Cytoplasm and Nucleus of the Cell
 
Number: 7,109,173
 
Filed: Feb. 7, 2005
 
Lead Inventor: Wilbert Gamble, Oregon State University
 
“The invention discloses the discovery of naturally occurring peptides that contain fatty acyl and prenyl moieties which permit the transfer of nucleotides, oligonucleotides, and polynucleotides into the cytoplasm and nucleus of cells,” the patent’s abstract states. “Their intrinsic properties cause them to tightly bind to nucleotides. This indicates that they might serve as nucleotide transporters. Experiments demonstrated that they permitted the transfer of nucleotides and polynucleotides into the cytoplasm and nucleus of cells,” it adds.
 
“The peptides, due to their ability to transport ribonucleic acids into cells, can be employed in gene silencing by RNAi and antisense therapy,” the abstract notes. “Among the ailments thought to benefit are: atherosclerosis by regulating cholesterol metabolism, cancer and similar diseases by delivering nucleic acids in chemotherapy. The peptides, due to their ability to transport ribonucleic acids into cells, can be employed in gene silencing.”
 

 
Title: Induction of RNA Interference by Aberrant RNA
 
Number: 20060205078
 
Filed: Dec. 14, 2005
 
Lead Inventor: Demian Obregon, University of South Florida College of Medicine
 
The patent application, its abstract states, covers a “method … for the induction of aberrant RNA interference by introducing aberrant RNAs into the cell wherein a long-stranded antisense or sense RNA is simultaneously introduced with a short 4- [to] 12-mer homologous or complementary or random RNA wherein the long-short RNAs induce sequence specific inhibition of the homologous gene within a cell. The invention disclosed herein can be used to suppress gene expression in vitro, ex vivo, or in vivo.”
 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.